Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Gene expression profiling of human sarcomas: insights into sarcoma biology.

Published version of a preprint

Abstract

Sarcomas are a biologically complex group of tumors of mesenchymal origin. By using gene expression microarray analysis, we aimed to find clues into the cellular differentiation and oncogenic pathways active in these tumors as well as potential biomarkers and therapeutic targets. We examined 181 tumors representing 16 classes of human bone and soft tissue sarcomas on a 12,601-feature cDNA microarray. Remarkably, 2,766 probes differentially expressed across this sample set clearly delineated the various tumor classes. Several genes of potential biological and therapeutic interest were associated with each sarcoma type, including specific tyrosine kinases, transcription factors, and homeobox genes. We also identified subgroups of tumors within the liposarcomas, leiomyosarcomas, and malignant fibrous histiocytomas. We found significant gene ontology correlates for each tumor group and identified similarity to normal tissues by Gene Set Enrichment Analysis. Mutation analysis done on 275 tumor samples revealed that the high expression of epidermal growth factor receptor (EGFR) in certain tumors was not associated with gene mutations. Finally, to further the investigation of human sarcoma biology, we have created an online, publicly available, searchable database housing the data from the gene expression profiles of these tumors (http://watson.nhgri.nih.gov/sarcoma), allowing the user to interactively explore this data set in depth.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-1699

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

See all 353

Metadata

Authors
Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S.
Affiliations
  • National Human Genome Research Institute (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • National Institutes of Health (US)
Venue
Cancer Research
Published
2005-10-15
Volume
65
Issue
20
Pages
9226-9235
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2118471037
Cited by
353
References
57
Citations by year
2025: 8 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 12 · 2020: 20 · 2019: 15 · 2018: 15 · 2017: 15 · 2016: 8 · 2015: 13 · 2014: 15 · 2013: 27 · 2012: 19
FWCI
18.20
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
sarcoma, gene expression profiling, bone sarcoma, soft tissue sarcoma, tumor classification, liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, tyrosine kinase, transcription factors, homeobox genes, EGFR, somatic mutations, therapeutic target, biomarkers
MeSH terms
Genes, Homeobox, Humans, Leiomyosarcoma, Liposarcoma, Protein-Tyrosine Kinases, Sarcoma, Signal Transduction, Cluster Analysis, Gene Expression Profiling, Wnt Proteins, Histiocytoma, Malignant Fibrous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene expression profiling of human sarcomas: insights into sarcoma biology. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-1699
The paper
Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005). Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-1699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.